Cargando…
Efficacy of Hepatitis B Virus Vaccines HBVaxpro40© and Fendrix© in Patients with Chronic Liver Disease in Clinical Practice
Chronic liver disease results in a low response rate to the hepatitis B virus vaccine. Information on the efficacy of the double adjuvanted vaccine FENDRIX(®) (3-O-desacyl-4’-monophosphoryl lipid A and aluminum phosphate) and single adjuvant HBVAXPRO(®)40 (aluminum hydroxyphosphate sulfate) in chron...
Autores principales: | Horta, Diana, Forné, Montserrat, Agustí, Anna, Raga, Agnes, Martín-Cardona, Albert, Hernández-Soto, Juana María, Ruiz-Ramírez, Pablo, Esteve-Comas, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416157/ https://www.ncbi.nlm.nih.gov/pubmed/36016211 http://dx.doi.org/10.3390/vaccines10081323 |
Ejemplares similares
-
Fendrix(®) Vaccine Effectiveness in Healthcare Workers Who Are Non-Responsive to Engerix B(®) Vaccination
por: Tejada-Pérez, Juan José, et al.
Publicado: (2021) -
Long-Term Effect of a Gluten-Free Diet on Diarrhoea- or Bloating-Predominant Functional Bowel Disease: Role of the ‘Low-Grade Coeliac Score’ and the ‘Coeliac Lymphogram’ in the Response Rate to the Diet
por: Fernández-Bañares, Fernando, et al.
Publicado: (2021) -
Immunogenicity and safety of a booster dose of the hepatitis B vaccine HepB-CpG (HEPLISAV-B®) compared with HepB-Eng (Engerix-B®) and HepB-AS04 (Fendrix®) in adults receiving hemodialysis who previously received hepatitis B vaccination and are not seroprotected: Results of a randomized, multicenter phase 3 study
por: Girndt, Matthias, et al.
Publicado: (2022) -
Women’s preference to apply shared decision-making in breast cancer screening: a discrete choice experiment
por: Hernández-Leal, María José, et al.
Publicado: (2022) -
Fatigue in out-patients with inflammatory bowel disease: Prevalence and predictive factors
por: Villoria, Albert, et al.
Publicado: (2017)